BANK VONTOBEL/CALL/NOVARTIS N/84/0.1/20.09.24 Share Price

Warrant

DE000VM369C5

Market Closed - Deutsche Boerse AG 18:47:39 05/07/2024 BST
1.4 EUR -2.78% Intraday chart for BANK VONTOBEL/CALL/NOVARTIS N/84/0.1/20.09.24
Current month+3.70%
1 month+16.67%
Date Price Change
05/07/24 1.4 -2.78%
04/07/24 1.44 +7.46%
03/07/24 1.34 -2.19%
02/07/24 1.37 -2.14%
01/07/24 1.4 +3.70%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 06:47 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Vontobel Vontobel
WKN VM369C
ISINDE000VM369C5
Date issued 18/10/2023
Strike 84 CHF
Maturity 20/09/2024 (76 Days)
Parity 10 : 1
Emission price 0.75
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.45
Lowest since issue 0.43
Delta0.83x
Omega 5.584
Premium1.83x
Gearing6.72x
Moneyness 1.150
Difference Strike -12.61 CHF
Difference Strike %-15.01%
Spread 0.14
Spread %9.03%
Intrinsic value 1.298

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107.7 USD
Average target price
111 USD
Spread / Average Target
+3.13%
Consensus